OraSure (OSUR) announced the acquisition of Sherlock Biosciences. This acquisition expands OraSure’s pipeline with the addition of Sherlock’s molecular diagnostics platform. Subject to regulatory approvals, revenue from Sherlock’s CT/NG test is expected to contribute to OTI’s growth beginning in 2026.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks